Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

Novo Nordisk said it expects the pill to be launched in the United States in early January starting at $149 a month for the ...

Based Probiotic Category Ahead of 2026 Weight-Loss Season - Ingredient Research, Regulatory Context, and Evidence Gaps ...

Sacramento Telehealth Company Positions Multi-Form Compounded Semaglutide Access Through Licensed Medical Providers Ahead of ...

San Francisco biopharmaceutical company is testing GLP-1 drug on obese cats, but simpler solution exists, suggest ...

I'm a board-certified endocrinologist and , contrary to popular belief, choosing GLP-1 treatment isn't the ' easy way out.' ...

Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and ...

The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes ...

MBX Biosciences, Inc. is rated a Buy, driven by canvuparatide's once-weekly dosing advantage in hypoparathyroidism. Learn ...

In early 2025, the British Medical Journal (BMJ) reported 82 UK deaths from adverse reactions to semaglutide and tirzepatide, ...

FAT jab users have been told to do a specific exercise or risk ageing 10 years. New research reveals popular weight-loss injections, such as Mounjaro and Wegovy, can reduce lean muscle as well as ...

The wellness space has grown fast. The supplement market is crowded, and products vary widely in formulation and quality. People have noticed. Now, they’re asking for real results—outcomes, not just ...